Literature DB >> 965093

Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans Serovar pomona.

B Adler, S Faine.   

Abstract

Mice not normally susceptible to infection with Leptospira interrogans serovar pomona were rendered susceptible to lethal infections by treatment with a single dose of 300 mg of cyclophosphamide (Cy) per kg administered optimally from 4 days before to 1 day after infection. Cy-treated mice with either passively or actively acquired antibody were protected from death. Blood levels of leptospires in infected untreated and in Cy-treated mice remained similar until 2 days after infection, when untreated mice cleared the leptospires. Soon afterwards, opsonizing and agglutinating antibody appeared. Cy-treated mice given spleen cells from other normal or specifically immune mice were protected from infection. An important factor in the natural resistance of mice to leptospiral infection appears to be their capacity to produce circulating antibody within 48 to 72 h. Applications are suggested for this animal model in vaccination and protection studies.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 965093      PMCID: PMC420943          DOI: 10.1128/iai.14.3.703-708.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  RETICULOENDOTHELIAL PHAGOCYTOSIS OF VIRULENT LEPTOSPIRES.

Authors:  S FAINE
Journal:  Am J Vet Res       Date:  1964-05       Impact factor: 1.156

2.  INHIBITION OF HEMAGGLUTININ SYNTHESIS BY CYTOXAN.

Authors:  A W FRISCH; G H DAVIES
Journal:  Cancer Res       Date:  1965-06       Impact factor: 12.701

3.  Influence of cyclophosphamide on the delayed hypersensitivity of the mouse.

Authors:  J A Kerckhaert; G J Van den Berg; J M Willers
Journal:  Ann Immunol (Paris)       Date:  1974 Mar-Apr

4.  Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors.

Authors:  D L Camenga; N Nathanson; G A Cole
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

5.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

6.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

7.  Dairy farm fever in New Zealand: isolation of L pomona and L hardjo from a local outbreak.

Authors:  B W Christmas; J M Bragger; D G Till
Journal:  N Z Med J       Date:  1974-05-08

8.  Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody.

Authors:  B Rager-Zisman; A C Allison
Journal:  J Gen Virol       Date:  1973-06       Impact factor: 3.891

9.  Temporal appearance of opsonizing antibody to Francisella tularensis: detection by a radiometabolic assay.

Authors:  P G Canonico; A T McManus; J A Mangiafico; L S Sammons; V G McGann; H G Dangerfield
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

10.  Effect of cyclophosphamide on Histoplasma capsulatum infections in mice.

Authors:  G C Cozad; T J Lindsey
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

View more
  30 in total

1.  Protein and antigen profiles of prevalent serovars of Leptospira interrogans.

Authors:  J A Brown; R B LeFebvre; M J Pan
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  Potential anti-leptospiral compound, leptomycin B from marine Streptomyces indiaensis MSU5: taxonomy, fermentation, compound isolation, in vitro and in vivo efficacy.

Authors:  Jeyaraman Thirumalairaj; Karikalacholan Sivasankari; Kalimuthusamy Natarajaseenivasan; Ramasamy Balagurunathan
Journal:  World J Microbiol Biotechnol       Date:  2017-09-27       Impact factor: 3.312

3.  Lethal infection of C3H/HeJ and C3H/SCID mice with an isolate of Leptospira interrogans serovar copenhageni.

Authors:  Jarlath E Nally; Michael C Fishbein; David R Blanco; Michael A Lovett
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Interaction of leptospires with human polymorphonuclear neutrophils.

Authors:  B Wang; J Sullivan; G W Sullivan; G L Mandell
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Characterization of an antigenic oligosaccharide from Leptospira interrogans serovar pomona and its role in immunity.

Authors:  A Midwinter; T Vinh; S Faine; B Adler
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant.

Authors:  Amporn Srikram; Kunkun Zhang; Thanatchaporn Bartpho; Miranda Lo; David E Hoke; Rasana W Sermswan; Ben Adler; Gerald L Murray
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

7.  Comparative transcriptional and translational analysis of leptospiral outer membrane protein expression in response to temperature.

Authors:  Miranda Lo; Stuart J Cordwell; Dieter M Bulach; Ben Adler
Journal:  PLoS Negl Trop Dis       Date:  2009-12-08

8.  Heat stability of protective antigen of Leptospira interrogans serovar lai.

Authors:  T Masuzawa; R Nakamura; T Shimizu; Y Yanagihara
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

9.  Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection.

Authors:  Raghavan U M Palaniappan; Sean P McDonough; Thomas J Divers; Chia-Sui Chen; Ming-Jeng Pan; Mitsuharu Matsumoto; Yung-Fu Chang
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

10.  Effect of cyclophosphamide on experimental Nocardia asteroides infection in mice.

Authors:  B L Beaman; S Maslan
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.